Inhibitors

Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors.

1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body.

For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.).

The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects:
① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease.
②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak.
③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications.
④These drugs often have strong with serious adverse reactions.

2. Enzyme inhibitors: Enzyme inhibitors refer to compounds or drugs being capable of binding to enzyme and inhibit the enzymatic activity. It is clinically often applied of enzyme inhibitors to specially interfere with certain metabolic system to achieve the therapeutic purposes. For example, people use monoamine oxidase inhibitors as antidepressants; use carbonic anhydrase inhibitors as diuretics; use dopa decarboxylase inhibitors as antihypertensive drugs and use antibiotics such as penicillin, cephalosporins belonging to cell wall synthesis inhibitors. Enzyme inhibitors have applications in veterinary medicine and agriculture. In addition, people can also apply enzyme inhibitors to study the mechanism of the enzyme and metabolic pathways.

Enzyme inhibitors often have similar structure with their natural substrates. For designing the inhibitors according modification of natural substrate, people should first analyze and decide the function of each part of the molecule in binding with enzymes: for binding or not binding or repulsion; secondly, people should know the degree of tolerance of the binding site to the adjacent steric hindrance. Then people can replace each functional group to regulate the strength of interaction with the enzyme.

Inhibitors can be divided into reversible and irreversible, two classes. (1)Inhibitors binding with enzyme through non-covalent bonds are called reversible inhibitor. (2)Inhibitors binding to the enzyme via a covalent bond are irreversible inhibitors with strong binding affinity. They will not be affected by concentration change process such as dialysis or dilution after binding to the enzyme.

Click on the specific product, view the latest prices of the products, information, serving information
Structure Chemical Name CAS MF
S- (+)-Rolipram S- (+)-Rolipram 85416-73-5 C16H21NO3
(-)-MK-801 MALEATE (-)-MK-801 MALEATE 121917-57-5 C20H19NO4
REVERSINE REVERSINE 656820-32-5 C21H27N7O
SCRIPTAID SCRIPTAID 287383-59-9 C18H18N2O4
TG003 TG003 300801-52-9 C13H15NO2S
TYRPHOSTIN AG 1024 TYRPHOSTIN AG 1024 65678-07-1 C14H13BrN2O
PURVALANOL A PURVALANOL A 212844-53-6 C19H25ClN6O
GSK 343 GSK 343 1346704-33-3 C31H39N7O2
TAK-632 TAK-632 1228591-30-7 C27H18F4N4O3S
N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea 1020172-07-9 C30H28FN7O3
Octanoic acid, 6,8-bis[(phenylMethyl)thio]- Octanoic acid, 6,8-bis[(phenylMethyl)thio]- 95809-78-2 C22H28O2S2
A-674563 A-674563 552325-73-2 C22H22N4O
PF-04929113 PF-04929113 908115-27-5 C25H30F3N5O4
9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one 9-(6-Amino-3-pyridinyl)-1-[3-(trifluoromethyl)phenyl]benzo[h]-1,6-naphthyridin-2(1H)-one 1223001-51-1 C24H15F3N4O
Torin 1 Torin 1 1222998-36-8 C35H28F3N5O2
NVP-BGT226 NVP-BGT226 1245537-68-1 C28H25F3N6O2.C4H4O4
BAY 80-6946 (Copanlisib) BAY 80-6946 (Copanlisib) 1032568-63-0 C23H28N8O4
Filgotinib Filgotinib 1206161-97-8 C21H23N5O3S
BIX 02189 BIX 02189 1094614-85-3 C27H28N4O2
KGN KGN 4727-31-5 C20H15NO3
PCI 34051 PCI 34051 950762-95-5 C17H16N2O3
BRL 15572 HYDROCHLORIDE BRL 15572 HYDROCHLORIDE 193611-72-2 C25H28Cl2N2O
Oprozomib Oprozomib 935888-69-0 C25H32N4O7S
Skepinone-L Skepinone-L 1221485-83-1 C24H21F2NO4
NVP-BVU 972 NVP-BVU 972 1185763-69-2 C20H16N6
LDN-57444 LDN-57444 668467-91-2 C17H11Cl3N2O3
AS 604850 AS 604850 648449-76-7 C11H5F2NO4S
PD153035 HCl PD153035 HCl 183322-45-4 C16H14BrN3O2.HCl
tasquinimod tasquinimod 254964-60-8 C20H17F3N2O4
Ziprasidone Ziprasidone 122883-93-6 C21H21ClN4OS
(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE (E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE 658084-64-1 C24H29N3O2
2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID 2-[[(2E)-3-(2-NAPHTHALENYL)-1-OXO-2-BUTEN-1-YL]AMINO]BENZOIC ACID 321674-73-1 C21H17NO3
GSK461364 GSK461364 929095-18-1 C27H28F3N5O2S
AMG 458 AMG 458 913376-83-7 C30H29N5O5
Aurora A Inhibitor I Aurora A Inhibitor I 1158838-45-9 C31H31ClFN7O2
N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide N-(4-Chloro-3-methoxyphenyl)-2-pyridinecarboxamide 1161205-04-4 C13H11ClN2O2
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione 5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione 958852-01-2 C18H11N3O2S
FH 535 FH 535 108409-83-2 C13H10Cl2N2O4S
ARRY-380 ARRY-380 937265-83-3 C29H27N7O4S
SteMRegenin 1 SteMRegenin 1 1227633-49-9 C24H23N5OS
CX-5461 CX-5461 1138549-36-6 C27H27N7O2S
PHT-427 PHT-427 1191951-57-1 C20H31N3O2S2
MK-5108 (VX-689) MK-5108 (VX-689) 1010085-13-8 C22H21ClFN3O3S
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 1097917-15-1 C29H40N8O3S
GSK 2334470 GSK 2334470 1227911-45-6 C25H34N8O
7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine 7Methyl-5-(1-{[3-(trifluoroMethyl)phenyl]acetyl}-2,3-dihydro1Hindol-5-yl)7Hpyrrolo[2,3d]pyriMidin-4-aMine 1337531-36-8 C24H20F3N5O
Wnt-C59 Wnt-C59 1243243-89-1 C25H21N3O
LCL-161 LCL-161 1005342-46-0 C26H33FN4O3S
AZD2461 AZD2461 1174043-16-3 C22H22FN3O3
GNF 5837 GNF 5837 1033769-28-6 C28H21F4N5O2
SALEN-MN SALEN-MN 81065-76-1 C18H18ClMnN2O4
1-AZAKENPAULLONE 1-AZAKENPAULLONE 676596-65-9 C15H10BrN3O
Tasisulam Tasisulam 519055-62-0 C11H6BrCl2NO3S2
IGF-1R  Inhibitor  II,  N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea 196868-63-0 C18H16ClN3O2
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid 2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid 1173900-33-8 C22H24N4O4
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine 5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine 870483-87-7 C20H22N4O3
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine 1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine 343787-29-1 C24H27N5O2
YK-4-279 YK-4-279 1037184-44-3 C17H13Cl2NO4
2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine 2,2'-[[Dihydro-2-(4-pyridinyl)-1,3(2H,4H)-pyrimidinediyl]bis(methylene)]bis[N,N-dimethylbenzenamine 500579-04-4 C27H35N5
NVP-BHG712 NVP-BHG712 940310-85-0 C26H20F3N7O
Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro- Imidazo[4,5,1-jk][1,4]benzodiazepin-7(4H)-one, 2-[4-[(dimethylamino)methyl]phenyl]-5,6-dihydro- 328543-09-5 C19H20N4O
BMS707035 BMS707035 729607-74-3 C17H19FN4O5S
Tepotinib Tepotinib 1100598-32-0 C29H28N6O2
[4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone [4-[2-(1H-Indazol-3-yl)ethenyl]phenyl]-1-piperazinylmethanone 1000669-72-6 C20H20N4O
CCT 137690 CCT 137690 1095382-05-0 C26H31BrN8O
KW-2478 KW-2478 819812-04-9 C30H42N2O9
U0126-EtOH U0126-EtOH 1173097-76-1 C20H22N6OS2
SCH900776 SCH900776 891494-63-6 C15H18BrN7
GSK1838705A GSK1838705A 1116235-97-2 C27H29FN8O3
BML-275 BML-275 1219168-18-9 C24H27Cl2N5O
TAK-285 TAK-285 871026-44-7 C26H25ClF3N5O3
CZC24832 CZC24832 1159824-67-5 C15H17FN6O2S
MLN0905 MLN0905 1228960-69-7 C24H25F3N6S
MGluR5 inhibitor MGluR5 inhibitor 871362-31-1 C19H13ClF3N3O
XL765 XL765 1349796-36-6 C31H29N5O6S
ETP46464 ETP46464 1345675-02-6 C30H22N4O2
AZD 1080 AZD 1080 612487-72-6 C19H18N4O2
UNC-1215 UNC-1215 1415800-43-9 C32H43N5O2
LCZ696 LCZ696 936623-90-4 C48H58N6O8
Stattic Stattic 19983-44-9 C8H5NO4S
Fenspiride hydrochloride Fenspiride hydrochloride 5053-08-7 C15H21ClN2O2
SB 415286 SB 415286 264218-23-7 C16H10ClN3O5
GO 6983 GO 6983 133053-19-7 C26H26N4O3
6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE 6-AMINO-4-(4-PHENOXYPHENYLETHYLAMINO)QUINAZOLINE 545380-34-5 C22H20N4O
JNJ7777120 JNJ7777120 459168-41-3 C14H16ClN3O
SC-514 SC-514 354812-17-2 C9H8N2OS2
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione 905854-02-6 C23H19N3O2
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide 4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide 844442-38-2 C16H17Cl2N5O2
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol 3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol 677297-51-7 C18H14N6O2
PD173955 PD173955 260415-63-2 C21H16Cl2N4OS
ADL-5859 ADL-5859 850173-95-4 C24H29ClN2O3
GDC-0941 Bimesylate GDC-0941 Bimesylate 957054-33-0 C24H30N7O6S3
LY2228820 LY2228820 862507-23-1 C26H37FN6O6S2
IWR-1-endo IWR-1-endo 1127442-82-3 C25H19N3O3
CCT128930 CCT128930 885499-61-6 C18H20ClN5
AMG 900 AMG 900 945595-80-2 C28H21N7OS
SGI-1776 SGI-1776 1025065-69-3 C20H22F3N5O
Binimetinib Binimetinib 606143-89-9 C17H15BrF2N4O3
Icotinib Icotinib 610798-31-7 C22H21N3O4
WP1066 WP1066 857064-38-1 C17H14BrN3O
Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.